Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities

被引：1

作者：

Hummers, Laura K. ^{[1
]}

机构：

[1] Johns Hopkins Scleroderma Ctr, Baltimore, MD 21224 USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷 / 08期

关键词：

DOUBLE-BLIND;

D O I：

10.1002/art.42514

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1328 / 1330

页数：3

共 16 条

[1]

Allanore Y, 2018, ARTHRITIS RHEUMATOL, V70, P1634, DOI [10.5167/uzh-151637, 10.1002/art.40547]

[2] An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis [J].

Castelino, Flavia V. ;

Bain, Gretchen ;

Pace, Veronica A. ;

Black, Katharine E. ;

George, Leaya ;

Probst, Clemens K. ;

Goulet, Lance ;

Lafyatis, Robert ;

Tager, Andrew M. .

ARTHRITIS & RHEUMATOLOGY, 2016, 68 (12) :2964-2974

[3] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease [J].

Distler, Oliver ;

Highland, Kristin B. ;

Gahlemann, Martina ;

Azuma, Arata ;

Fischer, Aryeh ;

Mayes, Maureen D. ;

Raghu, Ganesh ;

Sauter, Wiebke ;

Girard, Mannaig ;

Alves, Margarida ;

Clerisme-Beaty, Emmanuelle ;

Stowasser, Susanne ;

Tetzlaff, Kay ;

Kuwana, Masataka ;

Maher, Toby M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26) :2518-2528

[4] Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis [J].

Dobrota, Rucsandra ;

Maurer, Britta ;

Graf, Nicole ;

Jordan, Suzana ;

Mihai, Carina ;

Kowal-Bielecka, Otylia ;

Allanore, Yannick ;

Distler, Oliver .

ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (10) :1743-1748

[5] A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials [J].

Domsic, Robyn T. ;

Medsger, Thomas A. ;

Gao, Shiyao ;

Laffoon, Maureen ;

Huang, Suiyuan ;

Wisniewski, Stephen ;

Spino, Cathie ;

Steen, Virginia ;

Lafyatis, Robert ;

Khanna, Dinesh .

RHEUMATOLOGY, 2023, 62 (04) :1543-1551

[6] Belimumab for the Treatment of Early Diffuse Systemic Sclerosis Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial [J].

Gordon, Jessica K. ;

Martyanov, Viktor ;

Franks, Jennifer M. ;

Bernstein, Elana J. ;

Szymonifka, Jackie ;

Magro, Cynthia ;

Wildman, Horatio F. ;

Wood, Tammara A. ;

Whitfield, Michael L. ;

Spiera, Robert F. .

ARTHRITIS & RHEUMATOLOGY, 2018, 70 (02) :308-316

[7] Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need [J].

Herrick, Ariane L. ;

Assassi, Shervin ;

Denton, Christopher P. .

NATURE REVIEWS RHEUMATOLOGY, 2022, 18 (05) :276-285

[8]

Khanna D, 2023, ARTHRITIS RHEUMATOL, V75, P1434, DOI 10.1002/art.42477

[9] New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis [J].

Khanna, Dinesh ;

Huang, Suiyuan ;

Lin, Celia J. F. ;

Spino, Cathie .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (05) :641-650

[10] Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Khanna, Dinesh ;

Lin, Celia J. F. ;

Furst, Daniel E. ;

Goldin, Jonathan ;

Kim, Grace ;

Kuwana, Masataka ;

Allanore, Yannick ;

Matucci-Cerinic, Marco ;

Distler, Oliver ;

Shima, Yoshihito ;

van Laar, Jacob M. ;

Spotswood, Helen ;

Wagner, Bridget ;

Siegel, Jeffrey ;

Jahreis, Angelika ;

Denton, Christopher P. .

LANCET RESPIRATORY MEDICINE, 2020, 8 (10) :963-974

← 1 2 →